Kyle Dempsey

Kyle Dempsey, MD, MBA, is a prominent figure in the healthcare investment sector, currently serving as a Partner at MVM Partners LLP, based in Boston, Massachusetts. He has been with MVM Partners since September 2017, initially as an Investment Principal before becoming a Partner in October 2018. His role focuses on investing in commercial-stage healthcare and life science companies.1

Education and Early Career

Dempsey holds a Doctor of Medicine (M.D.) from Harvard Medical School, where he graduated magna cum laude. He also earned a Master of Business Administration (MBA) from Harvard Business School and a Bachelor of Arts in Biochemistry with honors from Bowdoin College.1

Before his current position, Dempsey gained significant experience in various roles:

• He was a Clinic Director and Research Team Co-Director at Massachusetts General Hospital.
• He worked as a Consultant at Bain & Company, where he focused on healthcare-related projects.1

Board Memberships and Contributions

Dempsey is actively involved in several organizations as a board director or observer:

• HLS Therapeutics Inc.
• Optinose
• GT Medical Technologies, Inc. He also served as a board observer for MDxHealth and Biotheranostics, the latter of which was acquired by Hologic for $230 million.1

Recognition and Awards

Throughout his career, Dempsey has received numerous accolades, including the Dell Scholar, the Harry S. Truman Scholarship, and the George Mitchell Pioneer Scholar award, recognizing his leadership abilities and commitment to community service.1

Professional Skills

In addition to his investment expertise, Dempsey is proficient in Spanish at a professional working level, enhancing his ability to engage with diverse populations within the healthcare sector.1

Overall, Kyle Dempsey combines his medical background with business acumen to drive growth in the healthcare industry through strategic investments.